Concordance of Noncarcinogenic Endpoints in Rodent Chemical Bioassays

Risk Analysis

Volumn 35, Issue 6, 2015, Pages 1154-1166

  Wang, Bing ^a   Gray, George ^b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Hazard identification; Rodent bioassay; Site concordance

Indexed keywords

BIOHAZARDS; BIOLOGICAL ORGANS; RATS;

HAZARD IDENTIFICATION; KAPPA STATISTIC; LONG TERM STUDY; LONG TERM TESTS; NATIONAL TOXICOLOGY PROGRAMS; POSITIVE PREDICTIVE VALUES; PREDICTIVE VALUES; SITE CONCORDANCE;

TESTING;

BIOASSAY; CANCER; CARCINOGEN; HAZARD ASSESSMENT; LESION; PREDICTION; RODENT; TOXICOLOGY;

MUS; RATTUS; RODENTIA;

ANIMAL; BIOASSAY; FEMALE; MALE; MOUSE; RAT; TOXICITY TESTING;

ANIMALS; BIOLOGICAL ASSAY; FEMALE; MALE; MICE; RATS; TOXICITY TESTS;

EID: 84937034325     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/risa.12314     Document Type: Article

References (17)

1. Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, G., Lilly P, Sanders J, Sipes G, Bracken W, Dorato M, Van Deun K, Smith P, Berger B, Heller A. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regulatory Toxicology and Pharmacology, 2000; 32(1):56-67.
2. Gold LS, Bernstein L, Magaw R, Slone TH. Interspecies extrapolation in carcinogenesis: Prediction between rats and mice. Environmental Health Perspectives, 1989; 81:211-219.
3. Linkov I, Wilson R, Gray GM. Anticarcinogenic responses in rodent cancer bioassays are not explained by random effects. Toxicological Sciences, 1998; 43(1):1-9.
4. Chhabra R, Huff J, Schwetz B, Selkirk J. An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the national toxicology program. Environmental Health Perspectives, 1990; 86:313-321.
5. Bucher JR. The national toxicology program rodent bioassay. Annals of the New York Academy of Sciences, 2002; 982(1):198-207.
6. National Toxicology Program. Pathology code table: Microscopic terms by organ (large report), 2013.
7. Viera AJ, Garrett JM. Understanding interobserver agreement: The kappa statistic. Family Medicine, 2005; 37(5):360-363.
8. Carletta J. Assessing agreement on classification tasks: The kappa statistic. Computational Linguistics, 1996; 22(2):249-254.
9. Cochran WG. Some methods for strengthening the common [chi-squared] tests. Biometrics, 1954; 10:417-451.
10. Holman E, Gray G. Setting pesticide reference doses: A retrospective analysis examining key data and choices. Human and Ecological Risk Assessment: An International Journal, 2013; 20:1550-1564.
11. Swenberg JA. Alpha 2u-globulin nephropathy: Review of the cellular and molecular mechanisms involved and their implications for human risk assessment. Environmental Health Perspectives, 1993; 101(Suppl 6):39-44.
12. Haseman JK, Lockhart AM. Correlations between chemically related site-specific carcinogenic effects in long-term studies in rats and mice. Environmental Health Perspectives, 1993; 101(1):50-54.
13. Marone PA, Hall WC, Hayes AW. Reassessing the two-year rodent carcinogenicity bioassay: A review of the applicability to human risk and current perspectives. Regulatory Toxicology and Pharmacology, 2014; 68(1):108-118.
14. Collins FS, Gray GM, Bucher JR. Toxicology. Transforming environmental health protection. Science, 2008; 319(5865):906-907.
15. Tice RR, Austin CP, Kavlock RJ, Bucher JR. Improving the human hazard characterization of chemicals: A Tox21 update. Environmental Health Perspectives, 2013; 121(7):756-765.
16. Rhomberg L. Hypothesis-based weight of evidence: An approach to assessing causation and its application to regulatory toxicology. Risk Analysis, 2014. DOI: 10.1111/risa.12206.
17. Thomas RS, Philbert MA, Auerbach SS, Wetmore BA, Devito MJ, Cote I, Rowlands JC, Whelan MP, Hays SM, Andersen ME, Meek ME, Reiter LW, Lambert JC, Clewell HJ III, Stephens ML, Zhao QJ, Wesselkamper SC, Flowers L, Carney EW, Pastoor TP, Petersen DD, Yauk CL, Nong A. Incorporating new technologies into toxicity testing and risk assessment: Moving from 21st century vision to a data-driven framework. Toxicological Sciences, 2013; 136(1):4-18.